PeriRx sanctioned over false negotiation claims in patent suit
24-01-2022
cosmin4000 / iStockphoto.com
The US Patent and Trademark Office (USPTO) has issued a new CRISPR/Cas9 patent to the University of California (UC), the University of Vienna and microbiologist Emmanuelle Charpentier.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Emmanuelle Charpentier, University of Vienna, University of California, CRISPR/Cas9, gene editing
